{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T14:49:33Z","timestamp":1780670973863,"version":"3.54.1"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.radonc.2025.111322","type":"journal-article","created":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T23:02:23Z","timestamp":1765148543000},"page":"111322","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Image-guided intensity-modulated radiotherapy with reduced margins in patients with prostate cancer: Results of the RCMIGI randomized phase II trial"],"prefix":"10.1016","volume":"215","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9737-5655","authenticated-orcid":false,"given":"Olivier","family":"Riou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Fenoglietto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Jarlier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4899-5444","authenticated-orcid":false,"given":"Jessica","family":"Prunaretty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Aill\u00e8res","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6707-4141","authenticated-orcid":false,"given":"Gr\u00e9goire","family":"Poinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Debuire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Gourgou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4661-3561","authenticated-orcid":false,"given":"Laetitia","family":"Meignant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Segui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7773-5481","authenticated-orcid":false,"given":"Carmen","family":"Llacer Moscardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Charissoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Azria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2025.111322_b0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.radonc.2025.111322_b0010","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.radonc.2007.04.013","article-title":"Evidence-based radiation oncology: definitive, adjuvant and salvage radiotherapy for non-metastatic prostate cancer","volume":"84","author":"Jereczek-Fossa","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.111322_b0015","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/nrurol.2013.185","article-title":"Evolution of advanced technologies in prostate cancer radiotherapy","volume":"10","author":"Zaorsky","year":"2013","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.radonc.2025.111322_b0020","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1200\/JCO.23.02445","article-title":"Long-Term Analysis of NRG Oncology RTOG 0415: a Randomized phase III Noninferiority Study Comparing two Fractionation Schedules in patients with Low-Risk Prostate Cancer","volume":"42","author":"Lee","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2025.111322_b0025","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.eururo.2011.09.027","article-title":"Functional outcomes and complications following radiation therapy for prostate cancer: a critical analysis of the literature","volume":"61","author":"Bud\u00e4us","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.radonc.2025.111322_b0030","first-page":"6373","article-title":"Late toxicity rates following definitive radiotherapy for prostate cancer","volume":"19","author":"Ohri","year":"2012","journal-title":"Can J Urol"},{"key":"10.1016\/j.radonc.2025.111322_b0035","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.1200\/JCO.2009.25.3245","article-title":"Quality-of-life impact of primary treatments for localized prostate cancer in patients without hormonal treatment","volume":"28","author":"Pardo","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2025.111322_b0040","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.canrad.2010.07.225","article-title":"Dosimetric factors predictive of late toxicity in prostate cancer radiotherapy","volume":"14","author":"de Crevoisier","year":"2010","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.radonc.2025.111322_b0045","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1002\/cncr.24356","article-title":"Predictive models of toxicity with external radiotherapy for prostate cancer: clinical issues","volume":"115","author":"Valdagni","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2025.111322_b0050","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.radonc.2019.08.027","article-title":"Van Der Heide UA. ESTRO ACROP consensus guideline on the use of image guided radiation therapy for localized prostate cancer","volume":"141","author":"Ghadjar","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.111322_b0055","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3389\/fonc.2015.00018","article-title":"Potential applications of image-guided radiotherapy for radiation dose escalation in patients with early stage high-risk prostate cancer","volume":"5","author":"Nguyen","year":"2015","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2025.111322_b0060","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.canrad.2012.07.183","article-title":"Image-guided radiotherapy in prostate cancer: concepts and implications","volume":"16","author":"Cr\u00e9hange","year":"2012","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.radonc.2025.111322_b0065","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/COC.0b013e31827e4eb9","article-title":"Comparison of image-guided radiotherapy technologies for prostate cancer","volume":"37","author":"Das","year":"2014","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.radonc.2025.111322_b0070","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.radonc.2010.01.004","article-title":"The European Society of Therapeutic Radiology and Oncology-European Institute of Radiotherapy (ESTRO-EIR) report on 3D CT-based in-room image guidance systems: a practical and technical review and guide","volume":"94","author":"Korreman","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.111322_b0075","doi-asserted-by":"crossref","first-page":"405","DOI":"10.21873\/anticanres.16175","article-title":"CBCT-based Prostate IGRT with and without Implanted Markers: Assessment of Geometric Corrections and Time for Completion","volume":"43","author":"D.E Cicco","year":"2023","journal-title":"Anticancer Res"},{"key":"10.1016\/j.radonc.2025.111322_b0080","doi-asserted-by":"crossref","DOI":"10.1177\/15330338211016370","article-title":"Analysis of the Influence of Peripheral Anatomical changes for CBCT-Guided Prostate Cancer Radiotherapy","volume":"20","author":"Zhang","year":"2021","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.radonc.2025.111322_b0085","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3390\/curroncol32060291","article-title":"From CBCT to MR-Linac in Image-Guided Prostate Cancer Radiotherapy Towards Treatment Personalization","volume":"32","author":"Coc","year":"2025","journal-title":"Curr Oncol"},{"key":"10.1016\/j.radonc.2025.111322_b0090","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.clon.2020.09.010","article-title":"Image-Guided Radiotherapy for Pelvic Cancers: a Review of current evidence and Clinical Utilisation","volume":"32","author":"Webster","year":"2020","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.radonc.2025.111322_b0095","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.3109\/0284186X.2012.747698","article-title":"Radiopaque marker motion during pre-treatment CBCT as a predictor of intra-fractional prostate movement","volume":"52","author":"Bernchou","year":"2013","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2025.111322_b0100","first-page":"4117","article-title":"Image-guided radiotherapy with implanted markers and kilovoltage imaging and 6-dimensional position corrections for intrafractional motion of the prostate","volume":"33","author":"Badakhshi","year":"2013","journal-title":"Anticancer Res"},{"key":"10.1016\/j.radonc.2025.111322_b0105","doi-asserted-by":"crossref","first-page":"5013","DOI":"10.1120\/jacmp.v16i2.5013","article-title":"Intrafractional prostate motion during external beam radiotherapy monitored by a real-time target localization system","volume":"16","author":"Tong","year":"2015","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.radonc.2025.111322_b0110","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/1748-717X-7-101","article-title":"A comparison of radiographic techniques and electromagnetic transponders for localization of the prostate","volume":"7","author":"Foster","year":"2012","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.111322_b0115","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.ijrobp.2006.10.039","article-title":"Comparison of localization performance with implanted fiducial markers and cone-beam computed tomography for on-line image-guided radiotherapy of the prostate","volume":"67","author":"Moseley","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.111322_b0120","article-title":"Magnetic Resonance-Guided Reirradiation for Local Recurrence within the Prostate or in the Prostate Bed: Preliminary results of a prospective Registry Study","volume":"6","author":"Michalet","year":"2021","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.111322_b0125","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.3390\/cancers14081943","article-title":"Magnetic Resonance-Guided Reirradiation for Local Recurrence within the Prostate or in the Prostate Bed: One-Year Clinical results of a prospective Registry Study","volume":"14","author":"Michalet","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.radonc.2025.111322_b0130","article-title":"Online CBCT-based adaptive radiation with reduced PTV margins for prostate cancer: does reference plan comparison tell the whole story?","volume":"54","author":"Dahn","year":"2025","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.111322_bib381","doi-asserted-by":"crossref","first-page":"111087","DOI":"10.1016\/j.radonc.2025.111087","article-title":"Magnetic resonance guided stereotactic reirradiation for locally recurrent prostate cancers: Long-term results from a prospective registry study","volume":"211","author":"Buchalet","year":"2025","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.111322_b0135","doi-asserted-by":"crossref","unstructured":"Kishan AU, Lamb JM, Wilhalme H, Casado M, Chong N, Zello L, et al. Magnetic Resonance Imaging Versus Computed Tomography Guidance for Stereotactic Body Radiotherapy in Prostate Cancer: 2-year Outcomes from the MIRAGE Randomized Clinical Trial. European Urology 2024:S0302283824026885. DOI: 10.1016\/j.eururo.2024.10.026.","DOI":"10.1016\/j.eururo.2024.10.026"},{"key":"10.1016\/j.radonc.2025.111322_b0140","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1001\/jamaoncol.2022.6558","article-title":"Magnetic Resonance Imaging\u2013Guided vs Computed Tomography\u2013Guided Stereotactic Body Radiotherapy for Prostate Cancer: the MIRAGE Randomized Clinical Trial","volume":"9","author":"Kishan","year":"2023","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.radonc.2025.111322_b0145","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/j.ijrobp.2010.02.001","article-title":"Assessment of planning target volume margins for intensity-modulated radiotherapy of the prostate gland: role of daily inter- and intrafraction motion","volume":"78","author":"Tanyi","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.111322_b0150","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.ijrobp.2007.11.054","article-title":"Observations on Real-Time Prostate Gland Motion using Electromagnetic Tracking","volume":"71","author":"Langen","year":"2008","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.radonc.2025.111322_b0155","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.ijrobp.2012.08.001","article-title":"Adaptive radiation therapy for postprostatectomy patients using real-time electromagnetic target motion tracking during external beam radiation therapy","volume":"85","author":"Zhu","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.111322_b0160","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.ijrobp.2010.07.1978","article-title":"Analysis of Prostate Patient Setup and Tracking Data: potential intervention strategies","volume":"81","author":"Su","year":"2011","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.radonc.2025.111322_b0165","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.ijrobp.2006.10.026","article-title":"Multi-institutional clinical experience with the Calypso System in localization and continuous, real-time monitoring of the prostate gland during external radiotherapy","volume":"67","author":"Kupelian","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.111322_b0170","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ijrobp.2011.11.041","article-title":"Prostate Bed Motion during Intensity-Modulated Radiotherapy Treatment","volume":"84","author":"Klayton","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.radonc.2025.111322_b0175","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.urology.2009.10.072","article-title":"Reduction in Patient-reported Acute Morbidity in Prostate Cancer patients Treated with 81-Gy Intensity-modulated Radiotherapy using Reduced Planning Target volume Margins and Electromagnetic Tracking: Assessing the Impact of Margin Reduction Study","volume":"75","author":"Sandler","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.radonc.2025.111322_b0180","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3389\/fonc.2014.00279","article-title":"A phase II Trial of Stereotactic Ablative Body Radiotherapy for Low-Risk Prostate Cancer using a Non-Robotic Linear Accelerator and Real-Time Target Tracking: Report of Toxicity, Quality of Life, and Disease Control Outcomes with 5-Year Minimum Follow-up","volume":"4","author":"Mantz","year":"2014","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2025.111322_b0185","unstructured":"L\u00e9gifrance. Code de la sant\u00e9 publique, Article L1121-3. 2016. https:\/\/www.legifrance.gouv.fr\/codes\/article_lc\/LEGIARTI000032722865 (accessed August 18, 2025)."},{"key":"10.1016\/j.radonc.2025.111322_b0190","unstructured":"L\u00e9gifrance. Bonnes Pratiques Cliniques pour les recherches biom\u00e9dicales portant sur des m\u00e9dicaments \u00e0 usage humain. 2006. https:\/\/www.legifrance.gouv.fr\/jorf\/id\/JORFTEXT000000819256 (accessed August 18, 2025)."},{"key":"10.1016\/j.radonc.2025.111322_b0195","unstructured":"L\u00e9gifrance. Loi n\u00b0 2004-806 du 9 ao\u00fbt 2004 relative \u00e0 la politique de sant\u00e9 publique. 2023. https:\/\/www.legifrance.gouv.fr\/loda\/id\/JORFTEXT000000787078 (accessed August 18, 2025)."},{"key":"10.1016\/j.radonc.2025.111322_b0200","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. International Council for Harmonisation Guidelines. 2025. https:\/\/www.ich.org\/page\/ich-guidelines (accessed August 18, 2025)."},{"key":"10.1016\/j.radonc.2025.111322_b0205","unstructured":"The World Medical Association. Declaration of Helsinki. 2024. https:\/\/www.wma.net\/what-we-do\/medical-ethics\/declaration-of-helsinki\/ (accessed August 18, 2025)."},{"issue":"7\u20138","key":"10.1016\/j.radonc.2025.111322_bib383","doi-asserted-by":"crossref","first-page":"104720","DOI":"10.1016\/j.canrad.2025.104720","article-title":"Tumour and normal tissue radiosensitivity: 2025 updateRadiosensibilit\u00e9 des tumeurs et des tissus sains\u202f: mise \u00e0 jour 2025","volume":"29","author":"Lapierre","year":"2025","journal-title":"Cancer Radiother"},{"issue":"5","key":"10.1016\/j.radonc.2025.111322_bib384","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.canrad.2024.06.002","article-title":"Radiation-induced lymphocyte apoptosis assay: Primetime for routine clinical use?","volume":"28","author":"Azria","year":"2024","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.radonc.2025.111322_b0210","doi-asserted-by":"crossref","first-page":"304","DOI":"10.5603\/RPOR.a2023.0029","article-title":"Implementation of the Calypso system: a commissioning experience","volume":"28","author":"Prunaretty","year":"2023","journal-title":"Rep Pract Oncol Radiother"},{"key":"10.1016\/j.radonc.2025.111322_b0215","doi-asserted-by":"crossref","DOI":"10.1118\/1.4794502","article-title":"Evaluation of multiple image-based modalities for image-guided radiation therapy (IGRT) of prostate carcinoma: a prospective study","volume":"40","author":"Mayyas","year":"2013","journal-title":"Med Phys"},{"key":"10.1016\/j.radonc.2025.111322_b0220","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ijrobp.2006.01.050","article-title":"Target localization and real-time tracking using the Calypso 4D localization system in patients with localized prostate cancer","volume":"65","author":"Willoughby","year":"2006","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.radonc.2025.111322_b0225","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ijrobp.2012.11.027","article-title":"Prostate hypofractionated radiation therapy: injection of hyaluronic acid to better preserve the rectal wall","volume":"86","author":"Chapet","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.111322_b0230","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20210242","article-title":"Prostate hypofractionated radiotherapy (62Gy at 3.1Gy per fraction) with injection of hyaluronic acid: final results of the RPAH1 study","volume":"94","author":"Chapet","year":"2021","journal-title":"Br J Radiol"},{"key":"10.1016\/j.radonc.2025.111322_b0235","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S1470-2045(16)30102-4","article-title":"Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial","volume":"17","author":"Dearnaley","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2025.111322_b0240","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1200\/JCO.2016.71.7397","article-title":"Randomized Trial of a Hypofractionated Radiation Regimen for the Treatment of Localized Prostate Cancer","volume":"35","author":"Catton","year":"2017","journal-title":"JCO"},{"key":"10.1016\/j.radonc.2025.111322_b0245","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.ijrobp.2014.11.027","article-title":"Prostate Hypofractionated Radiation Therapy with Injection of Hyaluronic Acid: Acute Toxicities in a phase 2 Study","volume":"91","author":"Chapet","year":"2015","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.radonc.2025.111322_b0250","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2307\/2530297","article-title":"One-sample multiple testing procedure for phase II clinical trials","volume":"38","author":"Fleming","year":"1982","journal-title":"Biometrics"},{"key":"10.1016\/j.radonc.2025.111322_b0255","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.radonc.2025.111322_b0260","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.4103\/jcrt.JCRT_463_17","article-title":"Interfraction prostate displacement during image-guided radiotherapy using intraprostatic fiducial markers and a cone-beam computed tomography system: a volumetric off-line analysis in relation to the variations of rectal and bladder volumes","volume":"15","author":"Ingrosso","year":"2019","journal-title":"J Cancer Res Ther"},{"key":"10.1016\/j.radonc.2025.111322_b0265","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/s41597-024-03365-2","article-title":"Prostate intra-fraction motion recorded by transperineal ultrasound","volume":"11","author":"Ballhausen","year":"2024","journal-title":"Sci Data"},{"key":"10.1016\/j.radonc.2025.111322_b0270","article-title":"Dosimetric Comparison of MRI-Guided Versus Reduced Margin CT-Guided Stereotactic Body Radiotherapy for Localized Prostate Cancer: Post-Hoc Analysis of a phase III Trial","volume":"S0360\u20133016(25)00553-X","author":"Courtney","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.111322_b0275","article-title":"Clinical and Dosimetric Comparison between Non-image Guided Radiation Therapy and Fiducial-based image Guided Radiation Therapy with or without Reduced Margin in Intensity Modulated Radiation Therapy for Prostate Cancer","volume":"9","author":"Serizawa","year":"2024","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.111322_b0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110309","article-title":"Image guided radiotherapy in curative treatment for prostate cancer. 5-year results from a randomized controlled trial (RIC-trial)","volume":"196","author":"Lund","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.111322_b0285","doi-asserted-by":"crossref","first-page":"e534","DOI":"10.1016\/S1470-2045(22)00544-7","article-title":"Mechanisms, mitigation, and management of urinary toxicity from prostate radiotherapy","volume":"23","author":"Martin","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2025.111322_b0290","article-title":"Urethra-sparing prostate cancer radiotherapy: current practices and future insights from an international survey","volume":"51","author":"Gu\u00e9velou","year":"2025","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.111322_b0295","doi-asserted-by":"crossref","first-page":"962","DOI":"10.3390\/curroncol31020072","article-title":"Electromagnetic Transmitter-based Prostate Gating for Dose-Escalated Linac-based Stereotactic Body Radiation Therapy: an Evaluation of Intrafraction Motion","volume":"31","author":"De Bari","year":"2024","journal-title":"Curr Oncol"},{"key":"10.1016\/j.radonc.2025.111322_b0300","doi-asserted-by":"crossref","first-page":"N393","DOI":"10.1088\/0031-9155\/54\/17\/N03","article-title":"Tradeoffs of integrating real-time tracking into IGRT for prostate cancer treatment","volume":"54","author":"Zhu","year":"2009","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.radonc.2025.111322_b0305","doi-asserted-by":"crossref","DOI":"10.1007\/s13246-023-01304-w","article-title":"Dynamic intrafractional position monitoring with implanted fiducial markers for enhanced accuracy in radiotherapy of prostate cancer","author":"Mangesius","year":"2023","journal-title":"Phys Eng Sci Med"},{"key":"10.1016\/j.radonc.2025.111322_b0310","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ijrobp.2013.10.039","article-title":"Dosimetric implications of an injection of hyaluronic acid for preserving the rectal wall in prostate stereotactic body radiation therapy","volume":"88","author":"Chapet","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.111322_b0315","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.ijrobp.2018.07.2006","article-title":"Daily Versus Weekly Prostate Cancer image Guided Radiation Therapy: phase 3 Multicenter Randomized Trial","volume":"102","author":"de Crevoisier","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.111322_b0320","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2403365","article-title":"Phase 3 Trial of Stereotactic Body Radiotherapy in Localized Prostate Cancer","volume":"391","author":"Van As","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2025.111322_b0325","article-title":"CBCT-based online adaptive radiotherapy of the prostate bed: first clinical experience and comparison to nonadaptive conventional IGRT","author":"Fischer","year":"2024","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2025.111322_b0330","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1016\/j.prro.2017.09.010","article-title":"Effect of imaging frequency on PTV margins and geographical miss during image guided radiation therapy for prostate cancer","volume":"8","author":"Gupta","year":"2018","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.111322_b0335","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1748-717X-6-85","article-title":"Eight years of IMRT quality assurance with ionization chambers and film dosimetry: experience of the Montpellier Comprehensive Cancer Center","volume":"6","author":"Fenoglietto","year":"2011","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.111322_b0340","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.meddos.2012.09.001","article-title":"Implementing intensity modulated radiotherapy to the prostate bed: dosimetric study and early clinical results","volume":"38","author":"Riou","year":"2013","journal-title":"Med Dosim"},{"key":"10.1016\/j.radonc.2025.111322_b0345","article-title":"Three Years of Salvage IMRT for Prostate Cancer: results of the Montpellier Cancer Center","volume":"2012","author":"Riou","year":"2012","journal-title":"ISRN Urol"},{"key":"10.1016\/j.radonc.2025.111322_b0350","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.radonc.2019.11.016","article-title":"Long-term follow-up experience in anal canal cancer treated with Intensity-Modulated Radiation Therapy: Clinical outcomes, patterns of relapse and predictors of failure","volume":"144","author":"de Meric de Bellefon","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.111322_b0355","doi-asserted-by":"crossref","first-page":"4853","DOI":"10.3390\/cancers13194853","article-title":"Image-Guided Liver Stereotactic Body Radiotherapy using VMAT and Real-Time Adaptive Tumor Gating: Evaluation of the Efficacy and Toxicity for Hepatocellular Carcinoma","volume":"13","author":"Cantaloube","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.radonc.2025.111322_b0360","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.canrad.2017.07.048","article-title":"Prospective medical analysis of radiation therapist image repositioning during image-guided radiotherapy","volume":"22","author":"Lauche","year":"2018","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.radonc.2025.111322_b0365","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/1748-717X-6-147","article-title":"Bilateral kidney preservation by volumetric-modulated arc therapy (RapidArc) compared to conventional radiation therapy (3D-CRT) in pancreatic and bile duct malignancies","volume":"6","author":"Vieillot","year":"2011","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.111322_b0370","doi-asserted-by":"crossref","first-page":"4094","DOI":"10.1120\/jacmp.v14i4.4094","article-title":"Simultaneous integrated boost plan comparison of volumetric-modulated arc therapy and sliding window intensity-modulated radiotherapy for whole pelvis irradiation of locally advanced prostate cancer","volume":"14","author":"Riou","year":"2013","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.radonc.2025.111322_b0375","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s13014-015-0516-3","article-title":"Feasibility of accelerated partial breast irradiation with volumetric-modulated arc therapy in elderly and frail patients","volume":"10","author":"Riou","year":"2015","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.111322_b0380","doi-asserted-by":"crossref","first-page":"735","DOI":"10.4329\/wjr.v8.i8.735","article-title":"Helical tomotherapy and volumetric modulated arc therapy: New therapeutic arms in the breast cancer radiotherapy","volume":"8","author":"Lauche","year":"2016","journal-title":"World J Radiol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814025053265?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814025053265?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T05:38:42Z","timestamp":1770269922000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814025053265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":79,"alternative-id":["S0167814025053265"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2025.111322","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Image-guided intensity-modulated radiotherapy with reduced margins in patients with prostate cancer: Results of the RCMIGI randomized phase II trial","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2025.111322","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"111322"}}